Find Funding Opportunities

The NIH Blueprint for Neuroscience Research announces its intention to publish a Funding Opportunity Announcement (FOA) for investigators seeking support from the Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics). Applicants will be encouraged to utilize a customized set of contract resources and consultants from the BPN-Biologics Network to help advance their neuroscience-focused biotherapeutic discovery and development projects into the clinic. This Notice is provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Details of the planned FOA are provided below. The FOA is expected to be published in the spring of 2021 with an expected application due date in the summer of 2021.

The NIH Countermeasures Against Chemical Threats (CounterACT) program intends to publish a Funding Opportunity Announcement (FOA) to solicit applications to recruit Early Stage Investigators (ESI) to pursue exploratory/developmental, applied, proof of concept, or high risk-high impact research to discover safe and effective therapeutics to mitigate toxicities resulting from exposures to highly toxic chemicals.

This initiative will support (1) observational research to understand the role of structural racism and discrimination (SRD) in causing and sustaining health disparities, and (2) intervention research that addresses SRD in order to improve minority health or reduce health disparities.

The purpose of this Notice is to inform potential applicants that the Helping End Addiction Long-term (HEAL) Initiative and National Institute of Neurological Disorders and Stroke (NINDS), intends to publish a funding opportunity announcement RFA-21-15 as well as to announce a pre-application webinar on Thursday, March 11, 2021 from 3:00-4:00 pm EDT (12:00 -1:00pm PDT). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in March 2021 with an expected application due date in April 2021. This FOA will utilize the U19 Research Program Cooperative Agreements activity code. Details of the planned FOA and pre-application webinar are provided below.

The purpose of this Notice is to inform potential applicants that the Helping End Addiction Long-term (HEAL) Initiative and National Institute of Neurological Disorders and Stroke (NINDS), intends to publish a funding opportunity announcement RFA-21-16 as well as to announce a pre-application webinar on March 11, 2020 from 3:00-4:00 pm ET (12:00 -1:00pm PDT). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in March 2021 with an expected application due date in April 2021. This FOA will utilize the R34 Planning Cooperative Agreement activity code. Details of the planned FOA and pre-application webinar are provided below.

The purpose of this Notice is to announce the intention to issue an FOA to solicit new and renewal applications for autism centers of excellence (ACE) R01 Networks. A companion FOA will solicit applications for ACE Centers supported by the P50 activity code (see NOT-HD-21-007). An individual may serve as the Principal Investigator for an ACE Center or Network on only one application.

The purpose of this Notice is to announce the intention to issue an FOA to solicit new and renewal applications for autism centers of excellence (ACE) P50 Centers. A companion FOA will solicit applications for ACE Networks supported by the R01 activity code (see NOT-HD-21-006). An individual may serve as the Principal Investigator for an ACE Center or Network on only one application.

The purpose of this Request for Information (RFI) is to solicit public comment on the use of Common Data Elements (CDEs) in NIH-funded research, particularly in the context of research on COVID-19.

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PA-18-622 "Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed)". This Funding Opportunity Announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date: June 5, 2021, Revision, Resubmission and Renewal date: July 5, 2021, and AIDS application Due Date: September 7, 2021.

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PA-18-623 "Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed)". This Funding Opportunity Announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date: June 16, 2021; Revision, Resubmission and Renewal date: July 16, 2021, and AIDS application Due Date: September 7, 2021.